智能手机或可通过检测呼吸发现人体疾病信号

  美国癌症研究协会主办的《癌症预防研究》杂志上由Lori Sakoda博士发表的一篇文章显示，糖尿病患者中的不吸烟者服用糖尿病药物二甲双胍可降低患肺癌的风险。以色列理工学院Lori Sakoda博士是Hossam Haick教授领导的研究团队的一员，该团队正在开发一项可以附在智能手机上的产品,该产品可以及时检测到手机用户的一些紧急情况，比如用户一旦有疾病发作时，手机就可以立即检测到病人的呼吸情况，并对危及生命的疾病做出早期诊断。

  Haick教授研发的具有体内酒精筛查技术功能的智能手机是由欧洲委员会资助的SNIFFPHONE项目，Haick研发的手机可提供非侵入性、快速和低成本的疾病检测功能。它利用微观和纳米传感器感受人体呼气状态，然后传达信息到手机的信息处理系统进行解读，然后评估数据，做疾病诊断并确定其他细节问题。

  自从2006年以来Haick教授就参与研发了这项技术，该技术用近600万欧元(约680万美元)的资金投入来扩大“电子嗅觉器”的发展。该技术可以识别一般群体中有较高的可能患有特殊疾病的个体，该技术可以提醒人们及早治疗这些疾病。

  “SNIFFPHONE项目是一个成功的解决方案。它比目前疾病检测解决方案要更微小、更便宜、耗能小，最重要的是，它能既准确又非侵入式的进行直接的早期诊断。”Haick教授说。“早期诊断有助于及早挽救生命,尤其是类似癌症等危及生命的疾病。”（转化医学网360zhyx.com）

  本文系转化医学网原创编译整理，如需转载，请联系info@360zhyx.com。

  原文：Among nonsmokers who had diabetes, those who took the diabetes drug metformin had a decrease in lung cancer risk, according to a study in Cancer Prevention Research, a journal of the American Association for Cancer Research,by Lori Sakoda, PhD, MPH, research scientist at the research consortium headed by Professor Hossam Haick of the Technion-Israel Institute of Technology is developing a product that, when coupled with a smartphone, will be able to screen the user's breath for early detection of life-threatening diseases.

  Funded by a grant from the European Commission, the SNIFFPHONE project will link Prof. Haick's acclaimed breathalyzer screening technology to the smartphone to provide non-invasive, fast and cheap disease detection. It will work by using micro- and nano-sensors that read exhaled breath and then transfer the information through the attached mobile phone to an information-processing system for interpretation. The data is then assessed and disease diagnosis and other details are ascertained.

  The technology is supported by a recent €6 million (US$6.8 million) grant to the consortium to expand the "electronic nose" breathalyzer technology that Prof. Haick has been developing since he joined the Technion in 2006. That technology can identify individuals from the general population who have a higher likelihood for contracting a specific disease, and treat them in advance or at an early stage.

  "The SNIFFPHONE is a winning solution. It will be made tinier and cheaper than disease detection solutions currently, consume little power, and most importantly, it will enable immediate and early diagnosis that is both accurate and non-invasive," says Prof. Haick. "Early diagnosis can save lives, particularly in life-threatening diseases such as cancer."